PA
MJN

Parallel Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Parallel Advisors’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-217
Closed -$19K – 2309
2017
Q1 		$19K Buy
217
+19
+10% +$1.56K ﹤0.01% 989
2016
Q4 		$14K Buy
+198
New +$14.8K ﹤0.01% 1012

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Parallel Advisors's MJN Position: Q2 2017 in Review

Parallel Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 217 shares — an estimated $19K sold.

Parallel Advisors first reported a position in MJN in Q4 2016 and held it in 2 quarters. The position peaked at $19K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Parallel Advisors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Parallel Advisors sold 217 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $19K.
  • Parallel Advisors first reported a position in Mead Johnson Nutrition Company in Q4 2016 and held it in 2 quarters.
  • Parallel Advisors's Mead Johnson Nutrition Company position peaked at $19K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Parallel Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.